secwatch.observer — SEC 8-K summary
======================================

Issuer:     INSMED Inc (INSM)
CIK:        0001104506
Form:       8-K
Filed at:   2024-05-13T23:59:59+00:00
Accession:  0001140361-24-025709
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Insmed shareholders elect four Class III directors and approve 2019 Incentive Plan amendment
--------------------------------------------------------------------------------

- Elected David R. Brennan, Leo Lee, Carol A. Schafer, Melvin Sharoky as Class III directors until 2027.
- Advisory vote on 2023 executive compensation passed: 120.6M for, 8.1M against, 96.8K abstentions.
- Ratified Ernst & Young as independent auditor for 2024: 135.5M for, 4.2M against, 61.8K abstentions.
- Approved Amendment No. 1 to the 2019 Incentive Plan: 122.2M for, 6.6M against, 56.8K abstentions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1104506/000114036124025709/0001140361-24-025709-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1104506/000114036124025709/ef20029006_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-025709

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer